Wellington Management Group
VINC

Wellington Management Group’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Wellington Management Group’s Portfolio VINC Stock Details VINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-19,712
Closed -$4.02M – 2251
2021
Q4 		$4.02M Buy
19,712
+3,066
+18% +$765K ﹤0.01% 1517
2021
Q3 		$5.38M Sell
16,646
-29,253
-64% -$8.53M ﹤0.01% 1492
2021
Q2 		$11.9M Sell
45,899
-783
-2% -$239K ﹤0.01% 1220
2021
Q1 		$18M Buy
+46,682
New +$18.8M ﹤0.01% 1099

Other funds holding VINC

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
SRC
Sage Rhino Capital Menlo Park, California $617M AUM 28.74% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group's VINC Position: Q1 2022 in Review

Wellington Management Group sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q1 2022, closing a stake of 19,712 shares — an estimated $4.02M sold.

Wellington Management Group first reported a position in VINC in Q1 2021 and held it in 4 quarters. The position peaked at $18M in Q1 2021. 68 funds tracked by Wall St. Rank hold VINC as of Q1 2022.

  • Wellington Management Group reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Wellington Management Group sold 19,712 Vincerx Pharma, Inc. Common Stock shares in Q1 2022, an estimated $4.02M.
  • Wellington Management Group first reported a position in Vincerx Pharma, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
  • Wellington Management Group's Vincerx Pharma, Inc. Common Stock position peaked at $18M in Q1 2021.
  • 68 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q1 2022.

Based on Wellington Management Group's 13F filing for Q1 2022, filed 16 May 2022.